About me

Dr. Joan-Marc Servitja is a senior researcher at the group Pathogenesis and Prevention of Diabetes, leading different projects related to islet biology and diabetes. He has also received contracts from the pharmaceutical industry in order to test novel applications of existing drugs as potential treatments for type 1 and type 2 diabetes. During the last years, he has authored more than 20 articles on diabetes research published in high impact journals. Currently, he is leading different research lines focused on the regulation of gene expression and inter-organ cross-talk in pancreatic islets with the ultimate goal to design novel therapeutic strategies for the treatment of type 2 diabetes.

Featured publications

Featured Projects

  • Inter-organ cross-talk and type 2 diabetes: effects of circulating exosomes on pancreatic islets

    Principal investigator: Anna Maria Novials Sarda, Joan Marc Servitja Duque
    Funder: Instituto de Salud Carlos III
    Code: PI20/00658
    Duration: 01/01/2021 - 31/12/2023
  • Benchtop NMR for Lab-On-Chip (BLOC)

    Principal investigator: Joan Marc Servitja Duque
    Funder: European Commission
    Code: 863037
    Duration: 01/01/2020 - 31/12/2023
  • BACE2, una nueva diana terapéutica para el tratamiento de la diabetes tipo 2 y la obesidad.

    Principal investigator: Joan Marc Servitja Duque, Anna Maria Novials Sarda
    Funder: Instituto de Salud Carlos III
    Code: PI17/00879
    Duration: 01/01/2018 - 31/12/2020
  • Nuevas estrategias para el tratamiento de la diabetes: intervención sobre el estrés de retículo endoplásmico y la inflamación inducidos por los depósitos de amiloide en el islote pancreático.

    Principal investigator: Joan Marc Servitja Duque, Anna Maria Novials Sarda
    Funder: Instituto de Salud Carlos III
    Code: PI14/00447
    Duration: 01/01/2015 - 31/12/2017
  • Potential protective effects of an anti-inflammatory molecule on pancreatic beta-cells.

    Principal investigator: Joan Marc Servitja Duque, Anna Maria Novials Sarda
    Funder: CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER (Sede o evento); Instituto Grifols, S.A. ; Instituto Grifols, S.A. (Participante)
    Duration: 01/01/2013